Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model.
Kavian N, Servettaz A, Mongaret C, Wang A, Nicco C, Chéreau C, Grange P, Vuiblet V, Birembaut P, Diebold MD, Weill B, Dupin N, Batteux F.
Kavian N, et al. Among authors: weill b.
Arthritis Rheum. 2010 Nov;62(11):3477-87. doi: 10.1002/art.27626.
Arthritis Rheum. 2010.
PMID: 20583103
Free article.